Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Current Opinion in Supportive and Palliative Care|July 24, 2020
The evolving options in metastatic castration-sensitive prostate cancerZineb HamilouFuture Oncology (London, England)|November 15, 2017
Atezolizumab in urothelial bladder carcinomaZineb Hamilou, Pernelle Lavaud, Yohann LoriotCurrent Opinion in Supportive and Palliative Care|July 18, 2018
Treatment of hormone-naïve metastatic prostate cancerZineb Hamilou, Fred Saad, Karim FizaziEuropean Urology Focus|March 4, 2018
Treatment of Castration-naive Metastatic Prostate CancerZineb Hamilou, Giulia Baciarello, Karim FizaziExpert Opinion on Drug Safety|June 11, 2021
A drug safety evaluation of enzalutamide to treat advanced prostate cancerFred Saad, Zineb Hamilou, Jean-Baptiste LattoufExpert Review of Anticancer Therapy|March 1, 2018
Durvalumab in urothelial cancersPernelle Lavaud, Zineb Hamilou, Yohann Loriot, et al.Therapeutic Advances in Medical Oncology|October 28, 2021
Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?Anna Patrikidou, Thomas Zilli, Giulia Baciarello, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|December 15, 2025
Expert opinion on the management of anemia in prostate cancer patients receiving PARP inhibitorsLilian Hanna, Richard O'Dwyer, Zineb Hamilou, et al.Current Oncology (Toronto, Ont.)|December 24, 2025
A Rare Case of Metastatic Urethral Squamous Cell Carcinoma Presenting with Paraneoplastic Sweet Syndrome and Treated with PembrolizumabDan-Thanh Christine Nguyen, Zineb Hamilou, Evelyne Bonnardeaux, et al.Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2022
A single-center, multidisciplinary experience with radium-223 dichloride in men with metastatic castrate-resistant prostate cancerCédric Charrois-Durand, Fred Saad, Maroie Barkati, et al.Pageof 2